This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Beyond Barriers Therapeutics, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: John Marshall: Innovator in Central Nervous System Treatments
Introduction
John Marshall is a notable inventor based in Chicago, IL (US), recognized for his contributions to the field of medicine, particularly in the treatment of central nervous system disorders. With a total of 3 patents, his work focuses on innovative dosage forms that enhance the delivery of antioxidants for therapeutic purposes.
Latest Patents
Marshall's latest patents include groundbreaking formulations aimed at treating central nervous system disorders. One of his patents, titled "Sublingual or buccal dosage forms comprising antioxidants for treatment of central nervous system disorders," describes dosage forms that incorporate antioxidant compounds, such as N-acetyl cysteine (NAC). These forms are designed to be administered for conditions like traumatic brain injury or stroke. Another significant patent, "Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress," outlines methods for intranasal delivery of antioxidant compounds, facilitating effective treatment for similar CNS disorders.
Career Highlights
John Marshall is currently associated with Beyond Barriers Therapeutics, Inc., where he continues to innovate in the field of CNS treatments. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic formulations.
Collaborations
Marshall collaborates with talented individuals in his field, including Ryan Kole and Meriel Owen, who contribute to the development of his innovative projects.
Conclusion
John Marshall's contributions to the field of central nervous system treatments through his patents and collaborations highlight his dedication to advancing medical science. His innovative approaches promise to make a significant impact on the treatment of CNS disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile